im3D - About the company
im3D is a deadpooled company based in Turin (Italy), founded in 2004 by Andrea Di Camillo, Gianluca Dettori and Davide Dettori. It operates as a Medical imaging tools for cancer diagnosis. im3D has raised $2.6M in funding from Principia SGR. The company has 753 active competitors, including 160 funded and 42 that have exited. Its top competitors include companies like Perspectum, AIdoc and Qure.ai.
Company Details
im3D offers medical imaging tools for diagnosis. CAD Colon is a CAD (Computer Aided Detection) tool to assist in colon-rectal cancer screening and diagnosis. The workstation provides image elaboration on a large high definition flat panel screen. Patients can be viewed in both the prone and supine positions contemporaneously. The system recognizes and automatically eliminates faecal residue and marked liquids in all projections. Co-registration mode allows the user to simultaneously scroll the slices in the prone and supine acquisitions and in all the 2D views: axial, coronal and sagittal. Breast DTS is a solution for diagnosis of breast cancer. It supports analysis of digital mammography exams and tomosynthesis exams. It has a predefined and guided process for breast diagnosis, which can also be configured to alter the workflow. Users can measure and add dimensions. It also supports reporting, image management, computer aided detection for tomosynthesis images, tool management and resizing.
- Website
- i-m3d.com
- Social
- Email ID
- *****@i-m3d.com
- Phone Number
- +39 **********
Key Metrics
Founded Year
2004
Location
Turin, Italy
Stage
Deadpooled
Total Funding
$2.6M in 2 rounds
Latest Funding Round
Investors
Ranked
370th among 753 active competitors
Similar Companies
Sign up to download im3D's company profile
im3D's funding and investors
im3D has raised a total funding of $2.6M over 2 rounds. Its first funding round was on Jul 01, 2013. Its latest funding round was a Grant (prize money) round on Jan 01, 2018 for $*****. 1 investor participated in its latest round. im3D has 3 institutional investors.
Here is the list of recent funding rounds of im3D:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 01, 2018 | 3558459 | Grant (prize money) | 5984023 | 1935258 | 6084638 | 2431980 |
Jul 01, 2013 | 5747476 | Seed | 8712499 | 5188323 | 8109996 |
Access funding benchmarks and valuations. Sign up today!View details of im3D's funding rounds and investors
im3D's founders and board of directors
Founder? Claim ProfileHere are the details of im3D's key team members:
- Andrea Di Camillo: Co-Founder of im3D and founder of 1 other company. Contact Info: 1 email address
- Gianluca Dettori: Co-Founder of im3D and founder of 1 other company.
- Davide Dettori: Co-Founder & CEO of im3D.
View details of im3D's Founder profiles and Board Members
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
im3D's Competitors and alternates
Top competitors of im3D include Perspectum, AIdoc and Qure.ai. Here is the list of Top 10 competitors of im3D, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Perspectum 2012, Oxford (United Kingdom), Series C | Provider of precision medicine software for the diagnosis of liver diseases | $140M | 70/100 | |
2nd |  AIdoc 2016, New York City (United States), Series E | Developer of clinical AI solutions for healthcare imaging and patient management | $384M | 69/100 | |
3rd | Provider of AI-powered solutions for medical image analysis and reporting | $123M | 68/100 | ||
4th |  Subtle Medical 2017, Palo Alto (United States), Series B | AI-driven solutions for medical diagnostic imaging | $50M | 66/100 | |
5th |  Vista 2012, Palo Alto (United States), Series B | AI-guided software for clinicians to automate MRI exams | $38.2M | 64/100 | |
6th | IXICO 2004, London (United Kingdom), Public | AI-based medical image management and analysis solutions for healthcare organizations | - | 64/100 | |
7th |  Cleerly 2016, Denver (United States), Series C | Provider of an AI-driven platform for coronary artery disease assessment | $578M | 63/100 | |
8th | Provider of AI-based breast cancer screening software for clinics | $20.3M | 62/100 | ||
9th |  AI Medical Service 2017, Toshima City (Japan), Series C | AI-powered endoscopic software to detect early-stage gastrointestinal cancers | $122M | 62/100 | |
10th | ScreenPoint 2014, Nijmegen (Netherlands), Series C | Provider of AI-based medical image analysis systems | $33M | 62/100 | |
370th | Medical imaging tools for cancer diagnosis | $2.6M | 25/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on im3D's competitors? Click here to see the top ones
im3D's Investments and acquisitions
im3D has made no investments or acquisitions yet.
Reports related to im3D
Here is the latest report on im3D's sector:
Are you a Founder ?
FAQs about im3D
Explore our recently published companies
- Scylos - Nashville based, 2025 founded, Seed company
- Techhive Technologies - Ikeja based, 2017 founded, Unfunded company
- Neumann Systems Group - Colorado Springs based, 2021 founded, Funding Raised company
- Orphi-tx.com - Funding Raised company
- H2Pump - Latham based, 2005 founded, Funding Raised company
- Bloom Pickleball - San Francisco based, 2011 founded, Funding Raised company
